ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $787,091 | +2.2% | 29,001 | +15.7% | 0.00% | 0.0% |
| Q2 2023 | $770,402 | +85882.4% | 25,061 | +0.7% | 0.00% | -25.0% |
| Q1 2023 | $896 | -75.9% | 24,890 | -73.5% | 0.00% | -78.9% |
| Q4 2022 | $3,715 | -99.9% | 94,003 | -9.0% | 0.02% | -9.5% |
| Q3 2022 | $4,149,000 | -1.2% | 103,260 | +3.4% | 0.02% | -4.5% |
| Q2 2022 | $4,199,000 | +7.7% | 99,887 | -0.2% | 0.02% | +15.8% |
| Q1 2022 | $3,900,000 | -22.7% | 100,106 | -20.9% | 0.02% | -20.8% |
| Q4 2021 | $5,045,000 | +70.6% | 126,623 | +54.7% | 0.02% | +50.0% |
| Q3 2021 | $2,957,000 | +363.5% | 81,826 | +425.3% | 0.02% | +300.0% |
| Q2 2021 | $638,000 | +17.1% | 15,576 | +24.6% | 0.00% | 0.0% |
| Q1 2021 | $545,000 | -21.4% | 12,504 | -9.8% | 0.00% | -20.0% |
| Q4 2020 | $693,000 | +264.7% | 13,863 | +206.4% | 0.01% | +150.0% |
| Q3 2020 | $190,000 | +95.9% | 4,524 | +126.2% | 0.00% | +100.0% |
| Q2 2020 | $97,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |